Innagural Liver Connect Agenda

AGENDA

Sponsored by: AbbVie

8:00 – 8:10 AM

Welcome/Introduction

In Memoriam of John C. Martin

Zobair Younossi, MD, MPH

8:10 – 8:55 AM

Keynote Address

Hepatitis C: The End of the Beginning and Possibly the Beginning of the End

Harvey Alter, MD, MACP

Session I

Marcelo Kugelmas, MD

8:55 – 9:25 AM

Hepatitis C: Elimination Strategies in the US

David Bernstein, MD

9:25 – 9:50 AM

Chronic Hepatitis B and D: Emerging Concepts and Treatment

Robert Gish, MD

9:50 – 10:10 AM

Panel Discussion/Q&A

Moderator: Marcelo Kugelmas, MD

10:10 – 10:25 AM

Break

Session II

Zobair Younossi, MD, MPH

10:25 – 10:50 AM

State of the Art on Alcoholic Liver Disease

Michael Lucey, MD

10:50 – 11:o5 AM

Identifying High Risk NASH Patients Using Noninvasive Techniques

Mazen Noureddin, MD, MHSc

11:05 – 11:35 AM

Panel/Case Discussion: Treatments for Weight Loss

Scott Isaacs, MD; Mary Rinella, MD; and Miriam Vos, MD, MSPH

Moderator: Zobair Younossi, MD, MPH

11:35 AM-12:00 PM

Emerging Therapies in NASH

Stephen Harrison, MD

12:00 – 12:15 PM

Panel Discussion/Q&A

Moderator: Zobair Younossi, MD, MPH

12:15 – 12:45 PM

Lunch

Session III

Kimberly Brown, MD

12:45 – 1:10 PM

Cholestatic Liver Disease: Current Management & Emerging Therapies

Kris Kowdley, MD

1:10 – 1:35 PM

Appropriate Clinical Decisions in the Treatment of Thrombocytopenia

Robert Brown, MD, MPH

1:35 – 2:00 PM

Panel Discussion/Q&A

Moderator: Kimberly Brown, MD

2:00 – 2:15 PM

Closing Remarks

Kimberly Brown, MD

Saturday, April 17, 2021

7:00 – 8:00 AM

Breakfast

8:00 – 8:10 AM

Introduction

Sammy Saab, MD

Session IV

Sammy Saab, MD

8:10 – 8:35 AM

Effective Management of Refractory Hepatic Encephalopathy

Jasmohan Bajaj, MD, MS

8:35 – 9:00 AM

The Puzzle in Hepatorenal Syndrome Management

Hugo Vargas, MD

9:00 – 9:15 AM

Panel Discussion/Q&A

Moderator: Sammy Saab, MD

9:15 – 9:30 AM

Break

Session V

Sammy Saab, MD

9:30 – 10:00 AM
State of the Art in Liver Transplantation

Michael Charlton, MBBS

10:00 – 10:25 AM

Hot Topics in Pediatric Liver Disease

Rohit Kohli, MBBS, MS

10:25 – 10:50 AM

COVID-19 and Managing Liver Disease

Rajender Reddy, MD

10:50 – 11:15 AM

Management of Hepatocellular Carcinoma in 2021

Laura Kulik, MD

11:15 – 11:35 AM

Panel Discussion/Q&A

Moderator: Sammy Saab, MD

11:35 – 11:45 AM

Meeting Summary

Steven Flamm, MD

11:45 – 11:50 AM

Closing Remarks

Zobair Younossi, MD, MPH

*Agenda is subject to change.

Agenda

This activity is supported by educational grants from AbbVie, Dova Pharmaceuticals, Exelixis, Inc., Gilead Sciences, Inc., Intercept Pharmaceuticals and Salix Pharmaceuticals.

Presented by

Accredited by